These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7604860)

  • 21. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D; Marshall R; Soisson K
    Lippincotts Prim Care Pract; 1999; 3(3):316-32. PubMed ID: 10711133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heart failure in adults].
    Trochu JN; Bouhour JB
    Rev Prat; 2002 Jan; 52(1):99-112. PubMed ID: 11852775
    [No Abstract]   [Full Text] [Related]  

  • 23. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diastolic heart failure -- a disease of the elderly].
    Witthaut R
    Dtsch Med Wochenschr; 2005 Mar; 130(12):704-9. PubMed ID: 15776355
    [No Abstract]   [Full Text] [Related]  

  • 25. Heart failure secondary to left ventricular systolic dysfunction. Therapeutic advances and treatment recommendations.
    Dracup K
    Nurse Pract; 1996 Sep; 21(9):56-8, 61, 65-8. PubMed ID: 8884795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of heart failure within the community].
    Ben-Ami H; Edoute Y
    Harefuah; 1999 Jan; 136(2):102-5, 176. PubMed ID: 10914171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How would chronic heart insufficiency actually be treated today?].
    Böger RH
    Dtsch Med Wochenschr; 2002 Aug; 127(34-35):1764-8. PubMed ID: 12192636
    [No Abstract]   [Full Text] [Related]  

  • 29. Heart failure. A review of current treatment strategies.
    Gross SB
    Adv Nurse Pract; 1999 Jun; 7(6):26-32; quiz 33-4. PubMed ID: 10624177
    [No Abstract]   [Full Text] [Related]  

  • 30. The diagnosis and management of chronic heart failure in the older patient.
    Gillespie ND
    Br Med Bull; 2005; 75-76():49-62. PubMed ID: 16495510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study reveals wide variations in guideline-based heart failure care.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jul; 15(13):10, 12. PubMed ID: 15272489
    [No Abstract]   [Full Text] [Related]  

  • 33. CHF disease management programs produce dramatic shift away from hospitalization.
    Healthc Demand Dis Manag; 1998 Jan; 4(1):7-10. PubMed ID: 10177380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current management of heart failure.
    Fisher C; McMurray JJ
    Practitioner; 2002 Jun; 246(1635):438-43. PubMed ID: 12073702
    [No Abstract]   [Full Text] [Related]  

  • 35. Heart failure in primary care: measuring the quality of care.
    James PA; Cowan TM; Graham RP; Jaén CR; Majeroni BA; Schwartz JS
    J Fam Pract; 1999 Oct; 48(10):790-8. PubMed ID: 12224677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Angiotensin converting enzyme inhibitors in the treatment of heart failure].
    Bettencourt P; Ferreira A
    Rev Port Cardiol; 2000 Dec; 19 Suppl 2():II51-6. PubMed ID: 11301911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of chronic heart failure. Recommendations of the Medical Commission of the German Medical Society (continuing education credit)].
    Med Monatsschr Pharm; 2001 Sep; 24(9):285-96; quiz 296, 316. PubMed ID: 11584761
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and management of heart failure in the outpatient setting.
    Wilbur J; James P
    Prim Care; 2005 Dec; 32(4):1115-29, ix. PubMed ID: 16326230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The biological treatment of heart failure: current status and prospect].
    Dai GZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):873-4. PubMed ID: 16266468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.